COMPARE · Data as of August 21, 2026

DOC vs SBRA

Verdict: Side-by-side breakdown using the Bull Rankings model. DOC scored 69.0, SBRA scored 71.0 — SBRA leads.
Compare another set
DOC
Healthpeak Properties, Inc.
REIT - Healthcare Facilities · Financial strength
67.5Fin
$21.33 · $15.1B
fundamentals as of
Strength gap
1.7
DOC leads
SBRA
Sabra Health Care REIT, Inc.
REIT - Healthcare Facilities · Financial strength
65.8Fin
$20.44 · $5.2B
fundamentals as of
  • Fastest growthSBRA+10.2%
  • Strongest balance sheetSBRA0.96
THE BULL RANKINGS SCORECARD67.5/ 100 · FIN STRENGTHPEER MEDIANREIT67.5
THE BULL RANKINGS SCORECARD65.8/ 100 · FIN STRENGTHPEER MEDIANREIT65.8
YieldDOC5.9%SBRA5.8%
RevDOC+4.5%SBRA+10.2%
D/EDOC1.09SBRA0.96
DOC
SBRA
5.9%A-
Yield
5.8%A-
+4.5%C+
Rev
+10.2%B
1.09B
D/E
0.96B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
DOCHealthpeak Properties, Inc.
REIT - Healthcare Facilities · $21.33 · beta 1.00
Why now
REIT - Healthcare Facilities · market cap $15.1b. 7% off the 52-week high of $22.95. 19 sell-side analysts rate this a Buy with a mean 1-yr target of $22.87 (implying +7% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Dividend payout 349% of earnings on a 5.9% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 3% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
SBRASabra Health Care REIT, Inc.
REIT - Healthcare Facilities · $20.44 · beta 0.64
Why now
REIT - Healthcare Facilities · market cap $5.2b. 10% off the 52-week high of $22.77. Revenue growing +10%, comfortably above the S&P median. 14 sell-side analysts rate this a Buy with a mean 1-yr target of $22.57 (implying +10% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Dividend payout 462% of earnings on a 5.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 2% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.